AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionCambridge Advisors Inc.
Latest Disclosed Ownership8,560 shares
Latest Disclosed Value $ 1,861,714
Cambridge Advisors Inc. reports 0.52% decrease in ownership of 4AB / AbbVie Inc.

On April 16, 2026 - Cambridge Advisors Inc. filed a 13F-HR form disclosing ownership of 8,560 shares of AbbVie Inc. (DE:4AB) valued at $1,587,024 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 8,605 shares of AbbVie Inc.. This represents a change in shares of -0.52% during the quarter. The current value of the position is $1,613,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F ABBVIE COM 00287Y109 8,560 -45 -0.52 1,862 -5.34 0.3613
2026-01-21 2025-12-31 13F ABBVIE COM 00287Y109 8,605 -15 -0.17 1,966 -1.45 0.3743
2025-10-15 2025-09-30 13F ABBVIE COM 00287Y109 8,620 -82 -0.94 1,996 23.53 0.3900
2025-07-16 2025-06-30 13F ABBVIE COM 00287Y109 8,702 -18 -0.21 1,615 -11.60 0.3376
2025-04-24 2025-03-31 13F ABBVIE COM 00287Y109 8,720 -159 -1.79 1,827 15.85 0.4002
2025-01-16 2024-12-31 13F ABBVIE COM 00287Y109 8,879 104 1.19 1,578 -8.95 0.3522
2024-10-23 2024-09-30 13F ABBVIE COM 00287Y109 8,775 -65 -0.74 1,733 14.25 0.3786
2024-07-11 2024-06-30 13F ABBVIE COM 00287Y109 8,840 65 0.74 1,516 -5.07 0.3523
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 8,775 -600 -6.40 1,598 9.99 0.3768
2024-01-17 2023-12-31 13F ABBVIE COM 00287Y109 9,375 -200 -2.09 1,453 1.75 0.3650
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 9,575 -505 -5.01 1,427 5.08 0.3832
2023-07-13 2023-06-30 13F ABBVIE COM 00287Y109 10,080 -1,085 -9.72 1,358 -23.66 0.3475
2023-04-13 2023-03-31 13F ABBVIE COM 00287Y109 11,165 50 0.45 1,779 -0.95 0.4555
2023-01-23 2022-12-31 13F ABBVIE COM 00287Y109 11,115 -350 -3.05 1,796 16.70 0.4822
2022-10-17 2022-09-30 13F ABBVIE COM 00287Y109 11,465 -50 -0.43 1,539 -12.76 0.4410
2022-07-18 2022-06-30 13F ABBVIE COM 00287Y109 11,515 -233 -1.98 1,764 -7.35 0.4821
2022-05-05 2022-03-31 13F ABBVIE COM 00287Y109 11,748 -37 -0.31 1,904 19.30 0.4537
2022-01-14 2021-12-31 13F ABBVIE COM 00287Y109 11,785 400 3.51 1,596 29.97 0.3605
2021-10-19 2021-09-30 13F ABBVIE COM 00287Y109 11,385 -231 -1.99 1,228 -6.12 0.2992
2021-07-21 2021-06-30 13F ABBVIE COM 00287Y109 11,616 -274 -2.30 1,308 1.63 0.3163
2021-04-22 2021-03-31 13F ABBVIE COM 00287Y109 11,890 1 0.01 1,287 1.02 0.3289
2021-01-25 2020-12-31 13F ABBVIE COM 00287Y109 11,889 1 0.01 1,274 22.38 0.3430
2020-10-15 2020-09-30 13F ABBVIE COM 00287Y109 11,888 2 0.02 1,041 -10.80 0.3066
2020-07-17 2020-06-30 13F ABBVIE COM 00287Y109 11,886 1 0.01 1,167 28.81 0.3654
2020-04-21 2020-03-31 13F ABBVIE COM 00287Y109 11,885 525 4.62 906 -9.94 0.3301
2020-01-28 2019-12-31 13F ABBVIE COM 00287Y109 11,360 -400 -3.40 1,006 13.03 0.3069
2019-10-25 2019-09-30 13F ABBVIE COM 00287Y109 11,760 -60 -0.51 890 3.49 0.2936
2019-07-26 2019-06-30 13F ABBVIE COM 00287Y109 11,820 0 0.00 860 -9.76 0.2839
2019-04-16 2019-03-31 13F ABBVIE COM 00287Y109 11,820 -50 -0.42 953 -12.89 0.3245
2019-01-29 2018-12-31 13F ABBVIE COM 00287Y109 11,870 100 0.85 1,094 -1.71 0.4070
2018-10-24 2018-09-30 13F ABBVIE COM 00287Y109 11,770 -300 -2.49 1,113 -0.45 0.3758
2018-07-30 2018-06-30 13F ABBVIE COM 00287Y109 12,070 0 0.00 1,118 -2.10 0.3952
2018-04-18 2018-03-31 13F ABBVIE COM 00287Y109 12,070 -265 -2.15 1,142 -4.27 0.4094
2018-01-26 2017-12-31 13F ABBVIE COM 00287Y109 12,335 0 0.00 1,193 8.85 0.4305
2017-10-27 2017-09-30 13F ABBVIE COM 00287Y109 12,335 0 0.00 1,096 22.60 0.4214
2017-07-24 2017-06-30 13F ABBVIE COM 00287Y109 12,335 -1,500 -10.84 894 -0.78 0.3613
2017-04-20 2017-03-31 13F ABBVIE COM 00287Y109 13,835 -200 -1.43 901 2.50 0.3716
2017-01-24 2016-12-31 13F ABBVIE COM 00287Y109 14,035 -100 -0.71 879 -1.35 0.3884
2016-10-21 2016-09-30 13F ABBVIE COM 00287Y109 14,135 0 0.00 891 1.83 0.3943
2016-07-26 2016-06-30 13F ABBVIE COM 00287Y109 14,135 0 0.00 875 8.43 0.3998
2016-04-25 2016-03-31 13F ABBVIE COM 00287Y109 14,135 1,039 7.93 807 3.99 0.3745
2016-01-28 2015-12-31 13F AbbVie Common Stock 00287Y109 13,096 261 2.03 776 11.17 0.4399
2015-10-23 2015-09-30 13F AbbVie Common Stock 00287Y109 12,835 -100 -0.77 698 -19.68 0.4123
2015-07-28 2015-06-30 13F AbbVie Common Stock 00287Y109 12,935 0 0.00 869 14.80 0.4897
2015-05-06 2015-03-31 13F AbbVie Common Stock 00287Y109 12,935 0 0.00 757 -10.52 0.4396
2015-02-17 2014-12-31 13F AbbVie Common Stock 00287Y109 12,935 12,935 846 0.5174
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.